Therapeutic Asset Ratings
1,584 results matching 1 filter
134,009 assets · 8,804 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
qt-219cx
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
qt-219cx
Systemic Sclerosis
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
Quisinostat
Glioblastoma
Nader Sanai
Early P1
C
(39)
RC001
Dravet Syndrome
Second Affiliated Hospital of Guangzhou Medical University
Early P1
C
(39)
rd06-03 cell
B-Cell Acute Lymphoblastic Leukemia
Anhui Provincial Hospital
Early P1
C
(39)
RD06-05 CART Cell
IgA Glomerulonephritis
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
RD06-05 CART Cell
Acquired Idiopathic Inflammatory Myopathy
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
RD06-05 CART Cell
Idiopathic Multidrug-Resistant Nephrotic Syndrome
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
RD06-05 CART Cell
Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
RD06-05 CART Cell
Systemic Sclerosis
The Children's Hospital of Zhejiang University School of Medicine
Early P1
C
(39)
Recombinant Human EGF-rP64K
Colorectal Cancer
Roswell Park Cancer Institute
Early P1
C
(39)
Recombinant Human Keratinocyte Growth Factor-2 For Inhalation
Acute Respiratory Distress Syndrome
Shanghai Zhongshan Hospital
Early P1
C
(39)
Recombinant Human Serum Albumin
Alzheimer Disease
Protgen Ltd
Early P1
C
(39)
Recombinant L-Ifn Adenovirus
Cervical Carcinoma
Shanghai Fengxian District Central Hospital
Early P1
C
(39)
Recombinant L-Ifn Adenovirus
Glioblastoma
Binhai Hospital of Fujian Medical University
Early P1
C
(39)
Red Yeast Rice,Ryr
Polycystic Ovary Syndrome
Sichuan Provincial People's Hospital
Early P1
C
(39)
Regorafenib
DC-CIK Treatment
JIANG LONGWEI
Early P1
C
(39)
Regorafenib
Immune Combination Therapy
JIANG LONGWEI
Early P1
C
(39)
Regorafenib
Iparomlimab and Tuvonralimab Injection
JIANG LONGWEI
Early P1
C
(39)
Rgl-193（High-Dose）
Parkinson Disease
Second Affiliated Hospital of Soochow University
Early P1
C
(39)
Rgl-193 (Low-Dose)
Parkinson Disease
Second Affiliated Hospital of Soochow University
Early P1
C
(39)
Riluzole
Treatment-Refractory Schizophrenia
King's College London
Early P1
C
(39)
Risperidone
LSD
University of Chicago
Early P1
C
(39)
Risvutatug Rezetecan
Metastatic Malignant Neoplasm In The Brain
Nader Sanai
Early P1
C
(39)
Rivastigmine
Auditory Perceptual Disorders
Yale University
Early P1
C
(39)
Showing 751 to 775 of 1,584 assets
Previous
Page 31 of 64
Next
